| Literature DB >> 25481079 |
Ryan C Conyers1, Jennifer R Mazzone1, Abhai K Tripathi2, David J Sullivan2, Gary H Posner3.
Abstract
Eight new artemisinin-derived trioxane dimer esters 5 have been prepared and tested for antimalarial efficacy in malaria-infected mice. At a single oral dose of only 6mg/kg combined with 18mg/kg of mefloquine, each of the dimer esters 5 outperformed the antimalarial drug artemether (2). The most efficacious dimer, dichlorobenzoate ester 5h, prolonged mouse survival past day 30 of infection with three of the four mice in this group having no detectable parasitemia and appearing and acting healthy on day 30.Entities:
Keywords: Antimalarial chemotherapy; Oral bioavailability; Single oral dose ACT; Trioxane dimer esters
Mesh:
Substances:
Year: 2014 PMID: 25481079 PMCID: PMC4277730 DOI: 10.1016/j.bmcl.2014.11.064
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823